CymitQuimica logo

CAS 19313-28-1

:

Dihydro-PGE1

Description:
Dihydro-PGE1, also known as Dihydroprostaglandin E1, is a synthetic derivative of prostaglandin E1 (PGE1), which is a naturally occurring lipid compound involved in various physiological processes. This substance is characterized by its role as a vasodilator, promoting blood flow and influencing platelet aggregation. Dihydro-PGE1 exhibits anti-inflammatory properties and is often studied for its potential therapeutic applications, particularly in cardiovascular health and conditions related to impaired blood circulation. The compound is typically administered in a clinical setting to manage specific medical conditions, such as peripheral vascular disease or erectile dysfunction. Its mechanism of action involves the modulation of cyclic AMP levels and the relaxation of smooth muscle tissues. As with many prostaglandins, Dihydro-PGE1 can have side effects, and its use must be carefully monitored. Overall, its unique chemical structure and biological activity make it a significant compound in pharmacology and medicinal chemistry.
Formula:C20H36O5
InChI:InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h15-17,19,21,23H,2-14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1
InChI key:InChIKey=DPOINJQWXDTOSF-DODZYUBVSA-N
SMILES:C(CCCCCC(O)=O)[C@@H]1[C@@H](CC[C@H](CCCCC)O)[C@H](O)CC1=O
Synonyms:
  • (11alpha,15S)-11,15-dihydroxy-9-oxoprostan-1-oic acid
  • (11α,15S)-11,15-Dihydroxy-9-oxoprostan-1-oic acid
  • (15S)-Dihydroprostaglandin E<sub>1</sub>
  • 11,15-Dihydroxy-9-ketoprostanoic acid
  • 11α,15-Dihydroxy-9-oxoprostanoic acid
  • 13,14-Dihydro-PGE<sub>1</sub>
  • 13,14-Dihydroprostaglandin E<sub>1</sub>
  • 13,14-Dihydroprostaglandinee1
  • 13,14-dihydro PGE1
  • 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]heptanoic acid
  • See more synonyms
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 6 products.